SMTL ID : 6b75.2 (1 other biounit)

Crystal Structure of human NAMPT in complex with NVP-LOQ594

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.53 Å

Oligo State

homo-dimer

Ligands

1 x CVP: 4-[(piperazin-1-yl)methyl]-N-{[4-({[(pyridin-3-yl)methyl]carbamoyl}amino)phenyl]methyl}benzamide(Non-covalent)

CVP.1: 17 residues within 4Å: Chain A: Y.18 Chain B: Y.188, H.191, F.193, R.196, D.219, V.242, A.244, P.273, S.275, T.304, Q.305, P.307, I.309, R.311, I.351, A.379 10 PLIP interactions: 1 interactions with chain A, 9 interactions with chain B pi-Stacking: A:Y.18, B:H.191, B:F.193 Hydrophobic interactions: B:D.219, B:P.273, B:P.307, B:I.309, B:I.309, B:I.351 Hydrogen bonds: B:S.275

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Palacios, D. et al., Identification and structure based design of cellularly active cyclo-propyl carboxamide Nicotinamide phosphoribosyltransferase (NAMPT) inhibitors. To Be Published

Release Date

2018-10-03

Peptides

Nicotinamide phosphoribosyltransferase: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
C

B
D

Nicotinamide phosphoribosyltransferase

Related Entries With Identical Sequence